Back to Authors

Davidovich, Irina

Mayo Clinic

Technion – Israel Institute of Technology

Citations 5

Glycan Node Analysis Detects Varying Glycosaminoglycan Levels in Melanoma-Derived Extracellular Vesicles
Gonçalves, Jenifer Pendiuk , Walker, Sierra A. , león, Jesús S. Aguilar Díaz de , Yang, Yubo, Davidovich, Irina, Busatto, Sara , Talmon, Yeshayahu , Wolfram, Joy , Pendiuk Goncalves, Jenifer , Sarkaria, Jann, Talmon, Yeshayahu , Wolfram, Joy , Sarkaria, Jann N. , Borges, Chad R.

International Journal of Molecular Sciences | May 10, 2023 | Volume: 24 | Issue: 10 | Pages: 8506

10.3390/ijms24108506 Get It

Extracellular vesicles (EVs) play important roles in (patho)physiological processes by mediating cell communication. Although EVs contain glycans and glycosaminoglycans (GAGs), these biomolecules have been overlooked due to technical challenges in comprehensive glycome analysis coupled with EV isolation. Conventional mass spectrometry (MS)-based methods are restricted to the assessment of N-linked glycans. Therefore, methods to comprehensively analyze all glyco-polymer classes on EVs are urgently needed. In this study, tangential flow filtration-based EV isolation was coupled with glycan node analysis (GNA) as an innovative and robust approach to characterize most major glyco-polymer features of EVs. GNA is a molecularly bottom-up gas chromatography-MS technique that provides unique information that is unobtainable with conventional methods. The results indicate that GNA can identify EV-associated glyco-polymers that would remain undetected with conventional MS methods. Specifically, predictions based on GNA identified a GAG (hyaluronan) with varying abundance on EVs from two different melanoma cell lines. Enzyme-linked immunosorbent assays and enzymatic stripping protocols confirmed the differential abundance of EV-associated hyaluronan. These results lay the framework to explore GNA as a tool to assess major glycan classes on EVs, unveiling the EV glycocode and its biological functions.
Unraveling multilayered extracellular vesicles: Speculation on cause
Broad, Kelly , Walker, Sierra A. , Davidovich, Irina, Witwer, Kenneth W. , Wolfram, Joy , Wolfram, Joy , Witwer, Kenneth W , Talmon, Yeshayahu

Journal of Extracellular Vesicles | February 3, 2023 | Volume: 12 | Issue: 2 | Pages: No page available

10.1002/jev2.12309 Get It

AbstractExtracellular vesicles (EVs) are cell‐released, heterogenous nanoparticles that play important roles in (patho)physiological processes through intercellular communication. EVs are often depicted as having a single lipid bilayer, but many studies have demonstrated the existence of multilayered EVs. There has been minimal inquiry into differences between unilamellar and multilamellar EVs in terms of biogenesis mechanisms and functional effects. This commentary speculates on potential causes and roles of multilamellar EVs and serves as a call to action for the research community to unravel the complex layers of EVs.
Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays
Busatto, Sara , Yang, Yubo, Iannotta, Dalila , Davidovich, Irina, Wolfram, Joy , Wolfram, Joy , Talmon, Yeshayahu

Journal of Extracellular Vesicles | April 1, 2022 | Volume: 11 | Issue: 4 | Pages: No page available

10.1002/jev2.12202 Get It

AbstractWith an exponential increase in extracellular vesicle (EV) studies in the past decade, focus has been placed on standardization of experimental design to ensure inter‐study comparisons and validity of conclusions. In the case of in vitro assays, the composition of cell culture media is important to consider for EV studies. In particular, levels of lipoproteins, which are critical components of the interstitial fluid, should be taken into consideration. Results from this study reveal that lipoprotein levels in cell culture medium impact the effects that EVs have on recipient cells. Additionally, evidence of EV binding and fusion to lipoprotein‐like structures in plasma is provided. However, it is unclear whether the impact of lipoproteins in cell culture is due to direct interactions with EVs, indirect effects, or a combination of both mechanisms. Taken together, cell culture studies performed in the absence of physiological levels of lipoproteins are unlikely to reflect interactions that occur between EVs and recipient cells in an in vivo environment.
Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines
Wang, Xinghua , Pham, Anthony , Lu, Kang , Walker, Sierra A. , Davidovich, Irina, Iannotta, Dalila , TerKonda, Sarvam P. , Talmon, Yeshayahu , Wolfram, Joy , Kang, Lu, Talmon, Yeshayahu , Wolfram, Joy , Kang, Lu, Shapiro, Shane A. , Pham, Si M.

Pharmaceutics | December 23, 2021 | Volume: 14 | Issue: 1 | Pages: 16

10.3390/pharmaceutics14010016 Get It

Extracellular vesicles (EVs) are cell-released nanoparticles that transfer biomolecular content between cells. Among EV-associated biomolecules, microRNAs (miRNAs/miRs) represent one of the most important modulators of signaling pathways in recipient cells. Previous studies have shown that EVs from adipose-derived mesenchymal stromal cells (MSCs) and adipose tissue modulate inflammatory pathways in macrophages. In this study, the effects of miRNAs that are abundant in adipose tissue EVs and other biogenic nanoparticles (BiNPs) were assessed in terms of altering Toll-like receptor 4 (TLR4)-induced cytokines. TLR-4 signaling in macrophages is often triggered by pathogen or damage-induced inflammation and is associated with several diseases. This study demonstrates that miR-451a, which is abundant in adipose tissue BiNPs, suppresses pro-inflammatory cytokines and increases anti-inflammatory cytokines associated with the TLR4 pathway. Therefore, miR-451a may be partially responsible for immunomodulatory effects of adipose tissue-derived BiNPs.
Adipose‐Derived Biogenic Nanoparticles for Suppression of Inflammation
Tian, Ming , Ticer, Taylor , Walker, Sierra A. , Pham, Anthony , Suh, Annie, Busatto, Sara , Davidovich, Irina, Al‐kharboosh, Rawan , Lewis‐Tuffin, Laura J. , Ji, Baoan , Quiñones‐Hinojosa, Alfredo , Rückert, Felix , Wolfram, Joy , Wang, Qikun, Walker, Sierra, Al-Kharboosh, Rawan, Lewis-Tuffin, Laura, Wolfram, Joy , Wang, Qikun , Talmon, Yeshayahu , Shapiro, Shane A.

Small | February 18, 2020 | Volume: 16 | Issue: 10 | Pages: No page available

10.1002/smll.201904064 Get It

Abstract Extracellular vesicles secreted from adipose‐derived mesenchymal stem cells (ADSCs) have therapeutic effects in inflammatory diseases. However, production of extracellular vesicles (EVs) from ADSCs is costly, inefficient, and time consuming. The anti‐inflammatory properties of adipose tissue‐derived EVs and other biogenic nanoparticles have not been explored. In this study, biogenic nanoparticles are obtained directly from lipoaspirate, an easily accessible and abundant source of biological material. Compared to ADSC‐EVs, lipoaspirate nanoparticles (Lipo‐NPs) take less time to process (hours compared to months) and cost less to produce (clinical‐grade cell culture facilities are not required). The physicochemical characteristics and anti‐inflammatory properties of Lipo‐NPs are evaluated and compared to those of patient‐matched ADSC‐EVs. Moreover, guanabenz loading in Lipo‐NPs is evaluated for enhanced anti‐inflammatory effects. Apolipoprotein E and glycerolipids are enriched in Lipo‐NPs compared to ADSC‐EVs. Additionally, the uptake of Lipo‐NPs in hepatocytes and macrophages is higher. Lipo‐NPs and ADSC‐EVs have comparable protective and anti‐inflammatory effects. Specifically, Lipo‐NPs reduce toll‐like receptor 4‐induced secretion of inflammatory cytokines in macrophages. Guanabenz‐loaded Lipo‐NPs further suppress inflammatory pathways, suggesting that this combination therapy can have promising applications for inflammatory diseases.